Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean and President for Academic Affairs at Mount Sinai Health System announced that Judith Aberg, MD, the Dr. George Baehr Professor of Clinical Medicine, has been appointed Dean of System Operations for Clinical Sciences at the Icahn School of Medicine at Mount Sinai. An internationally renowned […]
Washington University School of Medicine announces a new clinical trial for COVID-19 positive patients, STOP COVID Trial. Many patients testing positive for COVID-19 initially experience mild symptoms, but then clinically deteriorate in the second week of illness. The STOP COVID Trial tests a medication (fluvoxamine) for its anti-COVID properties for individuals ages 30 and up […]
The antidepressant fluvoxamine shows promise in preventing people infected with coronavirus from developing serious symptoms and having to be hospitalized, according to a nonrandomized study of California racetrack workers.
Highlighting members during Black History Month This Black History Month, the IDSA Foundation highlighted members that make this month even more special. While Black History Month is only one month, the IDSA Foundation focuses year-round on diversity and inclusion for the future of ID. In the video below, Dr. Mati Hlatshwayo Davis shares her thoughts […]
“If we don’t make it plain, we’re never going to address it or get through it” For a few days after May 16, 2020, Dr. Matifadza Hlatshwayo Davis was in a safe space or so she thought.
Global campaigns to eliminate two tropical parasitic worm infections have been hindered by lack of good diagnostic tools. Since the turn of the century, multinational mass drug-treatment efforts have cut the number of people at risk of lymphatic filariasis and onchocerciasis by more than half, but more than half a billion people remain at risk. […]
Meet the people behind today’s virology headlines. People just like you working to understand viruses and how they affect you. ‘Let’s Meet the Virologists’, hosted by Larissa Thackray, PhD, associate professor of Infectious Diseases, talks in Episode 19 with Rachel Presti, MD/PhD, an associate professor of Medicine and the medical director of the Infectious Diseases […]
Employees with close patient contact begin receiving Pfizer vaccine; older ages prioritized As part of a historic effort to end the COVID-19 pandemic, health-care personnel at Washington University School of Medicine in St. Louis and BJC HealthCare have begun receiving the first doses of a vaccine against the SARS-CoV-2 virus. Almost 10,000 doses of the […]
Five faculty members at Washington University School of Medicine in St. Louis have been elected fellows of the Infectious Diseases Society of America (IDSA). They are Ernie-Paul Barrette, MD, Jeffrey Henderson, MD, PhD, Stephen Liang, MD, and Hilary Reno, MD, PhD, all associate professors of medicine in the Department of Medicine’s Division of Infectious Diseases; and David Hunstad, MD, director […]
Matifadza Hlatshwayo Davis, MD, MPH, has been appointed as a member of the Board of Health of St. Louis by Mayor Lyda Krewson for a three year term. Dr. Hlatshwayo Davis indicated that she is “thrilled to get to serve our community by advancing the best possible public health standards for those that need them […]
Victoria J. Fraser, MD, Adolphus Busch Professor of Medicine, Jennifer A. Philips, MD, PhD, Associate Professor of Medicine and Molecular Microbiology & Co-director, Infectious Diseases Division, William G. Powderly, MD, J. William Campbell Professor of Medicine & Co-director, Infectious Diseases Division are delighted to announce that Dr. Gary Weil, Professor, Departments of Medicine and Molecular […]
This episode of ‘Show Me the Science’ reports on progress toward a vaccine and how to stay safe before vaccines become widely available “Show Me the Science,” hosted by Jim Dryden, director podcast services at Washington University School of Medicine, features infectious diseases physicians at Washington University School of Medicine in St. Louis discuss the […]
School of Medicine supports partnership working to end the HIV epidemic by 2030. On Tuesday, December 1, 2020, World AIDS Day, the St. Louis City Department of Health hosted a virtual celebration recognizing the first anniversary of Fast-Track Cities St. Louis and the launch of its new HIV data dashboard. Washington University School of Medicine […]
Grant awards set stage for next seven years of science-driven HIV clinical research. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced the clinical investigators and institutions that will lead four NIH HIV clinical trials networks over the next seven years to conduct the innovative, efficient clinical […]
David H. Perlmutter, MD, executive vice chancellor for medical affairs, recently announced several leadership appointments and promotions that will go into effect this year. Dr. Bill Powderly will be appointed Associate Dean for Clinical and Translational Sciences. This appointment recognizes Dr. Powderly’s role as Director of the Institute for Clinical and Translational Sciences (ICTS) and […]
A new episode of ‘Show Me the Science’, produced by the Office of Medical Public Affairs at Washington University School of Medicine in St. Louis , reports on the efforts of infectious diseases specialists and social work researchers to prevent COVID-19 outbreaks among people who are without adequate housing. People without permanent housing may be […]
Washington University School of Medicine in St. Louis is a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s phase 3 clinical research study, called the ENSEMBLE trial, to evaluate the safety and efficacy of Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S.
Rachel Presti, MD, PHD, associate professor of medicine is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for the COVID-19 vaccine trials at Washington University School of Medicine. Sharon Frey, MD, clinical director, Center for Vaccine Development and the Kinsella Endowed Chair in Internal Medicine Professor, associate director of clinical […]
Phase 3 trial involves hospitalized patients with moderate to severe disease One of the most vexing aspects of the COVID-19 pandemic is the novel coronavirus’s ability to turn the body’s immune system against the body. After the virus has been cleared from the body, the immune system sometimes continues to hurtle an arsenal of immune […]